Infinity Pharmaceuticals reported $13.39M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Amgen AMGN:US $ 12886M 702M
AstraZeneca AZN:LN 22740M 146M
Bristol Myers Squibb BMY:US $ 22821M 953M
Cytori Therapeutics CYTX:US $ 4.92M 0.95M
Eisai 4523:JP Y 313333M 8340M
Eli Lilly And LLY:US $ 13386M 1666.7M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Infinity Pharmaceuticals INFI:US $ 13.39M 0.09M
Johnson & Johnson JNJ:US $ 43390M 1836M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Seattle Genetics SGEN:US $ 531.29M 37.56M
Tg Therapeutics TGTX:US $ 54.66M 10.73M
Vascular Biogenics VBLT:US 11.05M 1.12M
YTE INCY:US $ 886.16M 31.86M